Market Insight
- Anesthesiologists are scarce in the Israeli health system, and are under great pressure
- Preparation of the anesthetic solution before a procedure takes time and increases the
probability of critical errors
The solution
- Our Ropivacaine is a long-acting local anesthetic product with a unique presentation that offers a safer and more efficient solution for Anesthesiologists
The Result
- After a prolong resistance to the new dosage form of the product by the hospitals, we identified the relevant KOLs and managed to overcome the obstacles and bear the primum price of the product.
Today, Ropivacaine is the most commonly used anesthesia in Israeli hospitals for obstetric procedures.
